Congress 108 - HR 1736 - Sickle Cell Treatment Act of 2003

Sponsor

Cosponsors

Topics

Blood transfusions Case management Child health Communication in medicine Community health services Congress Congressional reporting requirements Continuing education Continuum of care Economics and Public Finance Education Families Federal aid to child health services Federal aid to health facilities Genetic counseling Government Operations and Politics Health Health education Health insurance Higher education Medicaid Medical education Medical screening Medical tests Medically uninsured Nursing education Poor children Preventive medicine Sickle cell anemia Social Welfare Stroke

Full Text

View Full Bill Text

Votes

Summary

Sickle Cell Treatment Act of 2003 - Amends title XIX (Medicaid) of the Social Security Act (SSA) to include primary and secondary preventative medical strategies, treatment, and services, including genetic counseling and testing, for individuals who have Sickle Cell Disease as medical assistance under the Medicaid program.

Directs the Administrator of the Health Resources and Services Administration to conduct a demonstration program for the development and establishment of systemic mechanisms, including a National Coordinating Center, to improve the prevention and treatment of Sickle Cell Disease.

Actions

Sep 30, 2003

Sponsor introductory remarks on measure. (CR H9003)
Apr 24, 2003

Referred to the Subcommittee on Health.
Apr 10, 2003

Referred to the House Committee on Energy and Commerce.
Apr 10, 2003

Introduced in House

Amendments

Related Bills